Brief: Sino Biopharmaceutical Declares Interim Dividend Of HK5 Cents Per Share
18/08/2025 09:37
Aug 18 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK: INTERIM DIVIDEND OF HK5 CENTS PER SHARE HY REVENUE RMB 17.57 BILLION HY PROFIT ATTRIBUTABLE RMB 3.09 BILLION Further company coverage: 1177.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit